3,244 reports of this reaction
3.0% of all METFORMIN HYDROCHLORIDE TABLET reports
#3 most reported adverse reaction
NAUSEA is the #3 most commonly reported adverse reaction for METFORMIN HYDROCHLORIDE TABLET, manufactured by EPIC PHARMA, LLC. There are 3,244 FDA adverse event reports linking METFORMIN HYDROCHLORIDE TABLET to NAUSEA. This represents approximately 3.0% of all 107,050 adverse event reports for this drug.
Patients taking METFORMIN HYDROCHLORIDE TABLET who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for METFORMIN HYDROCHLORIDE TABLET, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for METFORMIN HYDROCHLORIDE TABLET:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 3,244 FDA reports for METFORMIN HYDROCHLORIDE TABLET. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.0% of all adverse event reports for METFORMIN HYDROCHLORIDE TABLET, making it one of the most commonly reported side effect.
If you experience nausea while taking METFORMIN HYDROCHLORIDE TABLET, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.